Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection. (November 2022)

• Record Type: Journal Article
• Authors: Merani, Rohan; Johnson, Mark W.; McCannel, Colin A.; Flynn, Harry W.; Scott, Ingrid U.; Hunyor, Alex P.
• Is Part Of: Journal of vitreoretinal diseases. Volume 6:Number 6(2022)
• Page Start: 443
• Page End: 451
• Publication Date: 2022-11
• Subjects: endophthalmitis -- intravitreal injection -- vascular endothelial growth factor; Retina -- Diseases -- Periodicals; Vitreous body -- Diseases -- Periodicals; Retina -- Diseases; Vitreous body -- Diseases; Periodicals; 617.735005
• DOI: 10.1177/24741264221116487
• Languages: English
• ISSNs: 2474-1264

Abstract

Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.